Digital health aimed at cost of care
Engagement and insights lead to action
- Put members in control of their health and promote positive behaviors with personalized digital coaching
- Take a data-driven approach to care management to equip care managers with real-time, actionable insights on health status
- Optimize chronic care programs with a universal experience across multiple cardiometabolic conditions
Reach populations with individualized care
- Implement a consistent and clinically based care model across the member population and across conditions
- Extend care management reach, capabilities, and cost effectiveness through the integration of an AI-driven digital health platform
- Deliver a seamless, personalized, and secure health experience that reaches broad sectors of your population
Be the brand for future care models
- Securely connect evidence-based, innovative technology to enhance your existing care management workflows, systems, and programs
- Access sophisticated, in-the-moment, real-time feedback to guide care decisions
- Welldoc supports your brand in the marketplace by providing a differentiated member experience
We’re helping to impact your outcomes
Average Cost Savings
$3048 - $3252 per person with type 2 diabetes, annually1
A1C Reduction
A 1.2 to 2.0-point mean A1C reduction in individuals living with type 2 diabetes 2,3
Net Promoter
70.1 NPS score +10 higher satisfaction scores than the leading competition
Case Study
2021
Case Study
A Model that Impacts Self-Care, ER Visits, and Costs
Empowering members to make more-informed choices may help reduce the costs associated with inappropriate care utilization. LifeScan, a leader in blood glucose monitoring and maker of the OneTouch brand, partnered with Welldoc to conduct a real-world observational study with a leading US health plan. Learn the vital role a virtual coach could play in improving diabetes self-management.
With Welldoc, we used OneTouch Reveal Plus, powered by BlueStar, to reach out to a number of Aetna Health members with type 2 diabetes. We saw an improvement in blood glucose and A1C, and we saw broad adoption and continued use.
—Kenneth Snow, MD, Clinical Portfolio Medical Director in the Transformation Section of CVS Health
Learn how Welldoc can help you improve outcomes
References:
1 IBM Watson Health. Estimating the economic value of a digital therapeutic in type 2 diabetes. Welldoc-sponsored report 2018. Published August 2018.
2 Tang PY, Duni J, Peeples MM, et al. Complementarity of digital health and peer support: “This Is What’s Coming.” Front Clin Diabetes Health. 2021;2. doi:10.3389/fcdhc.2021.646963
3 Quinn CC, Sareh PL, Shardell ML, Terrin ML, Barr EA, Gruber-Baldini AL. Mobile Diabetes Intervention for Glycemic Control. Journal of Diabetes Science and Technology. 2014;8(2):362-370. doi:10.1177/1932296813514503